Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (2913)	10/8/2010 10:56:41 AM
From: Steve Lokness	of 3158

And what do shareholders get? Tuesday, October 5, 2010 - ZymoGenetics settles lawsuits over Bristol-Myers deal By Seattle Times business staff ZymoGenetics said it has settled purported class-action lawsuits filed in King County Superior Court over its agreement to be acquired by Bristol-Myers Squibb. In a regulatory filing, the Seattle biotechnology company said it had agreed to provide additional disclosures about the process of reaching a deal with Bristol-Myers. The companies also will pay $625,000 in legal fees and expenses for the litigation. The settlement must be approved by the court and is contingent on the acquisition being completed. Copyright © The Seattle Times Company No link - copied from Yahoo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next